Inventor · disambiguated record
Hitoshi Ban
Also filed as: BAN HITOSHI
38 granted patents·20 pending applications·90 citations·filing 1999–2025
96Inventor score
Files withSUMITOMO PHARMA CO LTD23SUMITOMO DAINIPPON PHARMA CO LTD21BOSTON BIOMEDICAL INC5SUMITOMO PHARMA2BAN HITOSHI1
Top patents by PatentIndex Score
58 records- 0193US9248173B2WT1 antigen peptide conjugate vaccineSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Granted Feb 2, 2016·14 cites·28 claims
- 0292US10632192B2Pyrimidine compounds and their use as vaccine adjuvantsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Apr 28, 2020·6 cites·25 claims
- 0392US9181302B2WT1 antigen peptide conjugate vaccineSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2014·Granted Nov 10, 2015·17 cites·21 claims
- 0491US11911466B2Substituted pyrimidines as vaccine adjuvantsSUMITOMO PHARMA CO LTD·Filed 2022·Granted Feb 27, 2024·1 cites·27 claims
- 0591US11279694B2Alvocidib prodrugs and their use as protein kinase inhibitorsSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2017·Granted Mar 22, 2022·6 cites·4 claims
- 0691US10815241B2Optically active azabicyclo ring derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Oct 27, 2020·4 cites·10 claims
- 0791US10807993B2Dihydrochromene derivativesSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Oct 20, 2020·3 cites·28 claims
- 0890US11564920B25-heteroaryl-1H-pyrazol-3-amine derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Granted Jan 31, 2023·2 cites·18 claims
- 0989US11911381B2Optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Granted Feb 27, 2024·1 cites·15 claims
- 1088US11759509B2WT1 antigen peptide conjugate vaccineSUMITOMO PHARMA CO LTD·Filed 2018·Granted Sep 19, 2023·2 cites·13 claims
- 1187US12440560B2Substituted pyrimidines as vaccine adjuvantsSUMITOMO PHARMA CO LTD·Filed 2024·Granted Oct 14, 2025·0 cites·7 claims
- 1285US11369605B2Optically active azabicyclo ring derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Granted Jun 28, 2022·5 cites·39 claims
- 1385US8765920B2Tyrosine bioconjugation through aqueous Ene-like reactionsBARBAS III CARLOS F·Filed 2010·Granted Jul 1, 2014·6 cites·8 claims
- 1483US11795195B2Antibody-drug conjugates including hemiasterlin derivativeSUMITOMO PHARMA CO LTD·Filed 2018·Granted Oct 24, 2023·2 cites·24 claims
- 1583US11325921B2Optically active crosslinked cyclic secondary amine derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Granted May 10, 2022·2 cites·23 claims
- 1683US9828362B21,4-disubstituted imidazole derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2017·Granted Nov 28, 2017·5 cites·14 claims
- 1781US12263167B2Optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2024·Granted Apr 1, 2025·0 cites·19 claims
- 1875US12398149B2Dihydrochromene derivativesSUMITOMO PHARMA CO LTD·Filed 2023·Granted Aug 26, 2025·0 cites·9 claims
- 1974US10934309B2Tricyclic quinone derivativeBOSTON BIOMEDICAL INC·Filed 2018·Granted Mar 2, 2021·1 cites·1 claims
- 2073US10588952B2Conjugate vaccine using trimming function of ERAP1SUMITOMO DAINIPPON PHARMA CO LTD·Filed 2014·Granted Mar 17, 2020·2 cites·8 claims
- 2172US2025177395A1Optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 2272US2024059732A1Antibody-Drug Conjugates Including Hemiasterlin DerivativeSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 2370US11266738B2Substituted pyrimidines as vaccine adjuvantsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Mar 8, 2022·0 cites·5 claims
- 2470US10807945B21,4-disubstituted imidazole derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Oct 20, 2020·1 cites·27 claims
- 2569US11661397B21,4-disubstituted imidazole derivativeSUMITOMO PHARMA CO LTD·Filed 2020·Granted May 30, 2023·0 cites·7 claims
- 2669US11414394B2Process for producing a hydrate of a hydrochloride salt of 2,2′-((((((2-acetylnaphtho[2,3-b]furan-4,9-diyl)bis(oxy))bis(carbonyl))bis(azanediyl))bis(ethane-2,1-diyl))bis(azanediyl))diacetic acidSUMITOMO PHARMA ONCOLOGY INC·Filed 2020·Granted Aug 16, 2022·0 cites·8 claims
- 2766US11639357B2Dihydrochromene derivativesSUMITOMO PHARMA CO LTD·Filed 2020·Granted May 2, 2023·0 cites·31 claims
- 2864US12410154B25-heteroaryl-1H-pyrazol-3-amine derivativeSUMITOMO PHARMA CO LTD·Filed 2021·Granted Sep 9, 2025·0 cites·70 claims
- 2962US2024368138A1Self degradation-type cdk9 inhibitor prodrug and liposome encapsulating sameSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 3060US2014378668A1Tyrosine Bioconjugation through Aqueous Ene-Like ReactionsSCRIPPS RESEARCH INST·Filed 2014·Application pending·0 cites
- 3160US2025129049A11h-pyrazole-3-amine derivative having bicyclic backboneSUMITOMO PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 3258US2020171136A1Conjugate vaccine using trimming function of erap1SUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 3357US2025257055A1Tertiary amide derivatives substituted with 4-membered ring structureSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 3455US10800752B2Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancerBOSTON BIOMEDICAL INC·Filed 2018·Granted Oct 13, 2020·0 cites·12 claims
- 3555US10183925B2Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancerBOSTON BIOMEDICAL INC·Filed 2016·Granted Jan 22, 2019·0 cites·14 claims
- 3653US2016114019A1Wt1 antigen peptide conjugate vaccineSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Application pending·0 cites
- 3753US2025263415A1Tertiary amide derivatives substituted with 4-membered ring structureSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 3852US6420381B1Naphthyridine derivativesSUMITOMO PHARMA·Filed 1999·Granted Jul 16, 2002·10 cites·8 claims
- 3951US12178879B2Hemiasterlin derivative and antibody-drug conjugate thereofSUMITOMO PHARMA CO LTD·Filed 2020·Granted Dec 31, 2024·0 cites·14 claims
- 4050US12018093B2Hemiasterlin derivatives and antibody-drug conjugates including sameSUMITOMO PHARMA CO LTD·Filed 2018·Granted Jun 25, 2024·0 cites·25 claims
- 4150US2008096922A1Novel Sulfonamide derivativeDAINIPPON SUMITOMO PHARMA CO·Filed 2005·Application pending·0 cites
- 4250US2020368338A1Conjugate of wt1-derived peptides and composition comprising the sameSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 4349US2023287027A1Adjuvant with tlr4 agonist activitySUMITOMO PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 4447US7067528B21, 2-dihydro-2-oxo-1, 8-naphthyridine derivativeSUMITOMO PHARMA·Filed 2002·Granted Jun 27, 2006·0 cites·5 claims
- 4547US2020207782A1Chemically activated water-soluble prodrugSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 4647US2021100886A1Wt1 cancer antigen peptides and peptide conjugates comprising the peptidesSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 4746US12383608B2WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptidesSUMITOMO PHARMA CO LTD·Filed 2017·Granted Aug 12, 2025·0 cites·27 claims
- 4843US2021198283A1Optically active bridged piperidine derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 4942US12427192B2Water soluble adjuvant and composition containing sameSUMITOMO PHARMA CO LTD·Filed 2020·Granted Sep 30, 2025·0 cites·39 claims
- 5042US2005165057A1Novel piperidine derivativeFiled 2003·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hitoshi Ban files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →